4//SEC Filing
Prasad Arjun 4
Accession 0001171843-26-000059
CIK 0001738021other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:33 PM ET
Size
5.9 KB
Accession
0001171843-26-000059
Insider Transaction Report
Form 4
Prasad Arjun
Chief Commercial Officer
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2026-01-02+1,000,000→ 1,000,000 totalExercise: $5.17Exp: 2036-01-02→ COMMON STOCK (1,000,000 underlying)
Footnotes (2)
- [F1]The options were granted pursuant to the Compass Therapeutics, Inc. 2025 Inducement Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4).
- [F2]The options will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 2, 2027, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0002102138
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:33 PM ET
- Size
- 5.9 KB